Greenwich Lifesciences Stock Price Patterns
| GLSI Stock | USD 26.85 1.12 4.35% |
Momentum 64
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.34) | EPS Estimate Current Year (1.23) | EPS Estimate Next Year (1.34) | Wall Street Target Price 47.5 | EPS Estimate Current Quarter (0.36) |
Using Greenwich Lifesciences hype-based prediction, you can estimate the value of Greenwich Lifesciences from the perspective of Greenwich Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.
Greenwich Lifesciences Hype to Price Pattern
Investor biases related to Greenwich Lifesciences' public news can be used to forecast risks associated with an investment in Greenwich. The trend in average sentiment can be used to explain how an investor holding Greenwich can time the market purely based on public headlines and social activities around Greenwich Lifesciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Greenwich Lifesciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Greenwich Lifesciences.
The fear of missing out, i.e., FOMO, can cause potential investors in Greenwich Lifesciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Greenwich because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Greenwich Lifesciences after-hype prediction price | USD 36.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Greenwich | Build AI portfolio with Greenwich Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Greenwich Lifesciences After-Hype Price Density Analysis
As far as predicting the price of Greenwich Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Greenwich Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Greenwich Lifesciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Greenwich Lifesciences Estimiated After-Hype Price Volatility
In the context of predicting Greenwich Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Greenwich Lifesciences' historical news coverage. Greenwich Lifesciences' after-hype downside and upside margins for the prediction period are 24.17 and 45.44, respectively. We have considered Greenwich Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Greenwich Lifesciences is somewhat reliable at this time. Analysis and calculation of next after-hype price of Greenwich Lifesciences is based on 3 months time horizon.
Greenwich Lifesciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Greenwich Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Greenwich Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Greenwich Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.31 | 8.67 | 10.12 | 0.44 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
26.85 | 36.84 | 37.21 |
|
Greenwich Lifesciences Hype Timeline
Greenwich Lifesciences is currently traded for 26.85. The entity has historical hype elasticity of 10.12, and average elasticity to hype of competition of -0.44. Greenwich is projected to increase in value after the next headline, with the price projected to jump to 36.84 or above. The average volatility of media hype impact on the company the price is about 197.95%. The price growth on the next news is projected to be 37.21%, whereas the daily expected return is currently at 2.31%. The volatility of related hype on Greenwich Lifesciences is about 4587.3%, with the expected price after the next announcement by competition of 26.41. Greenwich Lifesciences currently holds 1.56 M in liabilities. Greenwich Lifesciences has a current ratio of 64.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Greenwich Lifesciences' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Greenwich Lifesciences Basic Forecasting Models to cross-verify your projections.Greenwich Lifesciences Related Hype Analysis
Having access to credible news sources related to Greenwich Lifesciences' direct competition is more important than ever and may enhance your ability to predict Greenwich Lifesciences' future price movements. Getting to know how Greenwich Lifesciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Greenwich Lifesciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CGTX | Cognition Therapeutics | (0.19) | 9 per month | 0.00 | (0.11) | 8.89 | (8.55) | 25.11 | |
| ATOS | Atossa Genetics | 0.52 | 9 per month | 0.00 | (0.24) | 6.75 | (9.93) | 42.59 | |
| TVGN | Tevogen Bio Holdings | 0.02 | 7 per month | 0.00 | (0.12) | 10.00 | (8.33) | 26.81 | |
| ONCY | Oncolytics Biotech | (0.08) | 10 per month | 4.37 | 0.01 | 12.64 | (7.62) | 27.46 | |
| SRZN | Surrozen | (2.02) | 7 per month | 4.54 | 0.20 | 13.34 | (10.10) | 34.29 | |
| HURA | TuHURA Biosciences | 0.02 | 10 per month | 0.00 | (0.03) | 13.89 | (10.53) | 61.26 | |
| SEER | Seer Inc | 0.02 | 6 per month | 0.00 | (0.05) | 3.72 | (2.21) | 7.59 | |
| IRD | Opus Genetics | 0.07 | 7 per month | 3.81 | 0.19 | 9.77 | (7.41) | 22.40 | |
| AGEN | Agenus Inc | 0.19 | 14 per month | 0.00 | (0.11) | 6.63 | (6.79) | 30.06 | |
| IMMX | Immix Biopharma | (0.44) | 7 per month | 3.74 | 0.22 | 14.88 | (6.08) | 28.79 |
Greenwich Lifesciences Additional Predictive Modules
Most predictive techniques to examine Greenwich price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Greenwich using various technical indicators. When you analyze Greenwich charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Greenwich Lifesciences Predictive Indicators
The successful prediction of Greenwich Lifesciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Greenwich Lifesciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Greenwich Lifesciences based on analysis of Greenwich Lifesciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Greenwich Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Greenwich Lifesciences's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Greenwich Stock analysis
When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |